Immunological Study of Helicobacter Pylori Infections on Pregnancy With Gestational Diabetes Mellitus

Authors

  • Hajar Dawood salman AL-Shujiri Department of Microbiology, College of Medicine, University of Babylon, Iraq
  • Ifad Kerim Abd Al-shibly University of Babylon, College of medicine, Department of microbiology
  • Huda H. Al-Hasnawy University of Babylon, College of medicine, Department of microbiology

Keywords:

Gestational Diabetes Mellitus (GDM), H. Pylori

Abstract

Background: The term "gestational diabetes mellitus" (GDM) refers to any degree of glucose intolerance that manifests itself or is first noticed during pregnancy. is a severe obstetric complication that affects between 5 and 10 percent of pregnancies globally; and is characterized by an insufficient response to insulin (Hyperglycemia). to make up for pregnancy's insulin-resistant condition. Gram-negative, spiral-shaped, microaerophilic H. pylori bacteria.Having dimensions of 0.5 to 1 pm in width and 2 to 4 pm in length. The body contains 2 to 6 flagella, and the flagella's motility grants and permits quick movement in viscous solutions, like the mucus layer of the gastric epithelial cell. Objective: The purpose of this study was to determine the relationship between [Helicobacter pylori (H. pylori) with Gestational diabetes mellitus (GDM)]. Materials and Method: HP-IgG and HP-IgM levels were evaluated in 89 pregnancy womens: 60 with Gestational Diabetes Mellitus (GDM) disease and 29 with healthy pregnancy. The study participants and the healthy controls varied in ages from 23 to 47 year. The enzyme-linked immunosorbent assay (ELISA) method measured HP-IgG and HP-IgM levels  in the blood. Results: The serum HP-IgG was greater in GDM patients than in controls (p 0.01) and HP-IgM (p 0.05). the current study discovered a Positive association between HP-IgG and HP-IgM with GDM. Conclusion: H. pylori infections are very common in GDM. The women with GDM, infections with H. pylori are rise the risks of GDM. The  H. pylori selection and extermination therapy before pregnancy help in avoiding GDM

References

Olmos-Ortiz, A., Flores-Espinosa, P., Díaz, L., Velázquez, P., Ramírez-Isarraraz, C., & Zaga-Clavellina, V. (2021). Immunoendocrine dysregulation during gestational diabetes mellitus: the central role of the placenta. International Journal of Molecular Sciences, 22(15), 8087.‏

Ali, H., Hussam, F., Al-Zubaidi, S. H., Hameed, N. M., Shakir, A., & Adhab, Z. H. Gestational Diabetes among Pregnant Women during Pregnancy in Baghdad, Iraq.‏

Chmiela, M., & Kupcinskas, J. (2019). Pathogenesis of Helicobacter pylori infection. Helicobacter, 24, e12638.‏

Li, Y., Lv, T., He, C., Wang, H., Cram, D. S., Zhou, L., ... & Jiang, W. (2020). Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin. Gut Pathogens, 12(1), 1-12.‏

Johnson, K. S., & Ottemann, K. M. (2018). Colonization, localization, and inflammation: the roles of H. pylori chemotaxis in vivo. Current opinion in microbiology, 41, 51-57.‏

Cen, L., Pan, J., Zhou, B., Yu, C., Li, Y., Chen, W., & Shen, Z. (2018). Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta‐analysis. Helicobacter, 23(1), e12457.‏

Mezmale, L., Coelho, L. G., Bordin, D., & Leja, M. (2020). Epidemiology of Helicobacter pylori. Helicobacter, 25, e12734.‏

Dixit, P., & Bhattacharyya, A. (2022). Understanding phosphorylation-mediated changes in the Subcellular localization and function of siah2 protein in the context of Helicobacter pylori-mediated gastric cancer (Doctoral dissertation, School of Biological Sciences, NISER, Bhubaneswar).‏

Care, D. (2019). Care in Diabetesd2019. Diabetes care, 42(1), S13-S28.‏

Smith, S., Fowora, M., & Pellicano, R. (2019). Infections with Helicobacter pylori and challenges encountered in Africa. World journal of gastroenterology, 25(25), 3183.‏

Szmuilowicz, E. D., Josefson, J. L., & Metzger, B. E. (2019). Gestational diabetes mellitus. Endocrinology and Metabolism Clinics, 48(3), 479-493.‏

Godbole, G., Mégraud, F., & Bessède, E. (2020). Diagnosis of Helicobacter pylori infection. Helicobacter, 25, e12735.‏

Mekonnen, D., Mengist, H. M., Derbie, A., Nibret, E., Munshea, A., He, H., ... & Jin, T. (2021). Diagnostic accuracy of serological tests and kinetics of severe acute respiratory syndrome coronavirus 2 antibody: A systematic review and meta‐analysis. Reviews in medical virology, 31(3), e2181.‏

Wensveen, T. T., Gašparini, D., Rahelić, D., & Wensveen, F. M. (2021). Type 2 diabetes and viral infection; cause and effect of disease. diabetes research and clinical practice, 172, 108637.‏

Siddiqui, R., Mungroo, M. R., Alharbi, A. M., Alfahemi, H., & Khan, N. A. (2022). The Use of Gut Microbial Modulation Strategies as Interventional Strategies for Ageing. Microorganisms, 10(9), 1869

Joo, E. H., Kim, Y. R., Kim, N., Jung, J. E., Han, S. H., & Cho, H. Y. (2021). Effect of endogenic and exogenic oxidative stress triggers on adverse pregnancy outcomes: preeclampsia, fetal growth restriction, gestational diabetes mellitus and preterm birth. International Journal of Molecular Sciences, 22(18), 10122.‏

Silva, C. M., Arnegard, M. E., & Maric-Bilkan, C. (2021). Dysglycemia in pregnancy and maternal/fetal outcomes. Journal of Women's Health, 30(2), 187-193.‏

Li, J., Fan, M., Ma, F., Zhang, S., & Li, Q. (2021). The effects of Helicobacter pylori infection on pregnancy-related diseases and fetal development in diabetes in pregnancy. Annals of Translational Medicine, 9(8).‏

Tang, Y., Yang, Y., & Lv, Z. (2021). Adverse pregnancy outcomes and Helicobacter pylori infection: A meta‐analysis. International Journal of Clinical Practice, 75(10), e14588.‏

Feng, C., Lv, P. P., Huang, C. C., Yang, S. Q., Yao, Q. P., Shen, J. M., & Jin, M. (2020). Sperm parameters and anti-Müllerian hormone remain stable with Helicobacter pylori infection: a cross-sectional study. BMC urology, 20(1), 1-9.‏

Xia, B., Wang, W., Lu, Y., & Chen, C. (2020). Helicobacter pylori infection increases the risk of metabolic syndrome in pregnancy: a cohort study. Annals of Translational Medicine, 8(14).‏

Ansari, S., & Yamaoka, Y. (2022). Helicobacter Pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: A Perspective of Clinical Relevance. Clinical Microbiology Reviews, 35(3), e00258-21.‏

Shedid, A. A. A., & Mourad, A. W. A. (2018). Obesity, Helicobacter pylori Infection and Preeclampsia: A triangle of Danger for pregnant women Running title: Helicobacter pylori Infection and Preeclampsia. The Egyptian Journal of Fertility of Sterility, 22(2), 44-52.‏

Cardaropoli, S., Rolfo, A., & Todros, T. (2014). Helicobacter pylori and pregnancy-related disorders. World Journal of Gastroenterology: WJG, 20(3), 654.‏

Lai, F. P., Tu, Y. F., Sheu, B. S., & Yang, Y. J. (2019). Maternal H. pylori seropositivity is associated with gestational hypertension but is irrelevant to fetal growth and development in early childhood. BMC pediatrics, 19, 1-9.‏

Downloads

Published

2023-10-02

Issue

Vol. 26 No. 2 (2023)

Section

ARTICLE

License

Copyright (c) 2023 University of Thi-Qar Journal Of Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.